- Capital Cube•5 months ago
Categories: Yahoo Finance Get free summary analysis Pierrel SpA reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Pierrel SpA – Recordati S.p.A., Enervit S.p.A. and Cosmo Pharmaceuticals NV (REC-IT, ENV-IT and COPN-CH) that have also reported for this period. Highlights Summary numbers: Revenues of EUR 3.31 ... Read more (Read more...)
- Capital Cube•last year
Click here to see latest analysisCapitalcube gives Pierrel SpA a score of 13.Our analysis is based on comparing Pierrel SpA with the following peers – Recordati S.p.A., MolMed S.p.A., Enervit S.p.A., COSMO Pharmaceuticals S.A. and Newron Pharmaceuticals S.p.A. (REC-IT, MLM-IT, ENV-IT, COPN-CH and NWRN-CH).Investment OutlookPierrel SpA has a fundamental score of 13 and has a […] (Read more...) The post Pierrel SpA – Value Analysis (MILAN:PRL) : December 24, 2015 appeared first on CapitalCube.
We're sorry this is all we were able to find about this topic.
PRL.MI : Summary for PIERREL - Yahoo Finance
Pierrel S.p.A. (PRL.MI)
Milan - Milan Delayed Price. Currency in EUR
Add to watchlist
|Day's Range||0.20 - 0.21|
|52 Week Range||0.16 - 0.32|
|PE Ratio (TTM)||-1.48|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|